Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc.

NASDAQ:TNYA

Overview | Financials
Company Name Tenaya Therapeutics, Inc.
Symbol TNYA
Currency USD
Price 1.91
Market Cap 150,678,181
Dividend Yield 0%
52-week-range 1.61 - 7.01
Industry Biotechnology
Sector Healthcare
CEO Mr. Faraz Ali M.B.A.
Website https://www.tenayatherapeutics.com

An error occurred while fetching data.

About Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by

Related Stocks

AN2 Therapeutics, Inc. logo

AN2 Therapeutics, Inc.

ANTX

1.08 USD

ESSA Pharma Inc. logo

ESSA Pharma Inc.

EPIX

5.74 USD

AC Immune SA logo

AC Immune SA

ACIU

3.11 USD

Precigen, Inc. logo

Precigen, Inc.

PGEN

0.937 USD

Alpine Immune Sciences, Inc. logo

Alpine Immune Sciences, Inc.

ALPN

64.97 USD

Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

DYN

33.39 USD

Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc.

LXRX

1.94 USD

Financials

Numbers are in millions USD

Numbers are in millions USD